Cull VS - Search Results

1

Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy.

Lenzo JC, Mansfield JP, Sivamoorthy S, Cull VS, James CM. Lenzo JC, et al. Among authors: cull vs. Cell Immunol. 2003 May;223(1):77-86. doi: 10.1016/s0008-8749(03)00150-3. Cell Immunol. 2003. PMID: 12914761

2

Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Cull VS, Bartlett EJ, James CM. Cull VS, et al. Immunology. 2002 Jul;106(3):428-37. doi: 10.1046/j.1365-2567.2002.01423.x. Immunology. 2002. PMID: 12100732 Free PMC article.

3

Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.

Bartlett EJ, Cull VS, Brekalo NL, Lenzo JC, James CM. Bartlett EJ, et al. Among authors: cull vs. Immunol Cell Biol. 2002 Oct;80(5):425-35. doi: 10.1046/j.1440-1711.2002.01103.x. Immunol Cell Biol. 2002. PMID: 12225378

4

Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis.

Bartlett EJ, Lenzo JC, Sivamoorthy S, Mansfield JP, Cull VS, James CM. Bartlett EJ, et al. Among authors: cull vs. Immunol Cell Biol. 2004 Apr;82(2):119-26. doi: 10.1046/j.0818-9641.2004.01234.x. Immunol Cell Biol. 2004. PMID: 15061762

5

Interferon subtype gene therapy for regulating cytomegalovirus disease.

James CM, Bartlett EJ, Mansfield JP, Cull VS. James CM, et al. Among authors: cull vs. Methods Mol Med. 2005;116:207-19. doi: 10.1385/1-59259-939-7:207. Methods Mol Med. 2005. PMID: 16000864

6

Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.

Lenzo JC, Fairweather D, Cull V, Shellam GR, James Lawson CM. Lenzo JC, et al. J Mol Cell Cardiol. 2002 Jun;34(6):629-40. doi: 10.1006/jmcc.2002.2003. J Mol Cell Cardiol. 2002. PMID: 12054850

7

Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice.

Cull VS, Broomfield S, Bartlett EJ, Brekalo NL, James CM. Cull VS, et al. Gene Ther. 2002 Oct;9(20):1369-78. doi: 10.1038/sj.gt.3301809. Gene Ther. 2002. PMID: 12365002

8

Type I interferon differential therapy for erythroleukemia: specificity of STAT activation.

Cull VS, Tilbrook PA, Bartlett EJ, Brekalo NL, James CM. Cull VS, et al. Blood. 2003 Apr 1;101(7):2727-35. doi: 10.1182/blood-2002-05-1521. Epub 2002 Nov 21. Blood. 2003. PMID: 12446459 Free article.

9

Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection.

Bartlett EJ, Cull VS, Mowe EN, Mansfield JP, James CM. Bartlett EJ, et al. Among authors: cull vs. Biol Proced Online. 2003;5:43-52. doi: 10.1251/bpo45. Epub 2003 Feb 17. Biol Proced Online. 2003. PMID: 12734557 Free PMC article.

10

Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.

Härle P, Cull V, Agbaga MP, Silverman R, Williams BR, James C, Carr DJ. Härle P, et al. J Virol. 2002 Jul;76(13):6558-67. doi: 10.1128/jvi.76.13.6558-6567.2002. J Virol. 2002. PMID: 12050368 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters